Metagenomi, Inc. Common Stock Cash Flow-to-Debt Ratio
Metagenomi, Inc. Common Stock cash flow-to-debt ratio. Metagenomi, Inc. Common Stock (MGX) has a Cash Flow-to-Debt Ratio of -0.32x as of June 2026, meaning its operating cash flow of $-19.51 Million could theoretically repay 0% of its total liabilities ($61.13 Million) in one year. See MGX free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Metagenomi, Inc. Common Stock (2021–2025)
Cash flow-to-debt ratio of Metagenomi, Inc. Common Stock from 2021 to 2025. Historical debt coverage capacity for Metagenomi, Inc. Common Stock across 5 annual periods. Check MGX cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Metagenomi, Inc. Common Stock Cash Flow-to-Debt Ratio by Year (2021–2025)
Metagenomi, Inc. Common Stock cash flow-to-debt ratio by year from 2021 to 2025. Year-by-year debt coverage analysis for Metagenomi, Inc. Common Stock. For the full cash flow conversion analysis, see cash efficiency ratio of Metagenomi, Inc. Common Stock.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -1.42x | $-88.89 Million | $62.51 Million | ▼ -17.0% |
| 2024 | -1.22x | $-109.07 Million | $89.74 Million | ▼ -565.4% |
| 2023 | -0.18x | $-91.41 Million | $500.43 Million | ▼ -400.5% |
| 2022 | 0.06x | $29.72 Million | $488.91 Million | ▼ -56.3% |
| 2021 | 0.14x | $24.26 Million | $174.54 Million | — |